Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares fell 3.8% on Wednesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Performance
The company has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The stock’s fifty day simple moving average is C$0.26 and its 200-day simple moving average is C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Recommended Stories
- Five stocks we like better than Emerald Health Therapeutics
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
